Review
doi: 10.1016/s1471-4892(03)00081-x.
Differentiation therapy
Affiliations
- PMID: 12901941
- DOI: 10.1016/s1471-4892(03)00081-x
Item in Clipboard
Review
Differentiation therapy
Curr Opin Pharmacol.
2003 Aug.
Abstract
Differentiation therapy is an area of oncology that is in its infancy. Theoretically, the concept of differentiation therapy involves turning a cancer cell "off" biologically and reverting to a more "benign" phenotype. Many agents have been studied over the past few years, with many already either in use clinically or showing future promise.
Similar articles
-
Differentiation agents in cancer therapy.Cancer Chemother Biol Response Modif. 1994;15:337-66. Cancer Chemother Biol Response Modif. 1994. PMID: 7779589 Review. No abstract available.
-
Retinoids.Curr Opin Oncol. 1993 Nov;5(6):1059-66. doi: 10.1097/00001622-199311000-00019. Curr Opin Oncol. 1993. PMID: 8305540 Review.
-
Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors.Expert Opin Investig Drugs. 2000 Dec;9(12):2923-34. doi: 10.1517/13543784.9.12.2923. Expert Opin Investig Drugs. 2000. PMID: 11093362 Review.
-
Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents.Vitam Horm. 2007;75:301-54. doi: 10.1016/S0083-6729(06)75012-9. Vitam Horm. 2007. PMID: 17368321 Review.
-
Differentiation therapy in acute myelogenous leukemia (non-APL).Leukemia. 2000 Mar;14(3):491-6. doi: 10.1038/sj.leu.2401714. Leukemia. 2000. PMID: 10720148 Review.
Cited by
-
Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia.Onco Targets Ther. 2016 Jul 20;9:4453-64. doi: 10.2147/OTT.S105664. eCollection 2016. Onco Targets Ther. 2016. PMID: 27499639 Free PMC article.
-
BTYNB, an inhibitor of RNA binding protein IGF2BP1 reduces proliferation and induces differentiation of leukemic cancer cells.Saudi J Biol Sci. 2023 Mar;30(3):103569. doi: 10.1016/j.sjbs.2023.103569. Epub 2023 Jan 25. Saudi J Biol Sci. 2023. PMID: 36816728 Free PMC article.
-
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention.Pharmaceutics. 2022 Jan 16;14(1):209. doi: 10.3390/pharmaceutics14010209. Pharmaceutics. 2022. PMID: 35057104 Free PMC article. Review.
-
p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.Semin Oncol. 2012 Feb;39(1):97-108. doi: 10.1053/j.seminoncol.2011.11.011. Semin Oncol. 2012. PMID: 22289496 Free PMC article. Review.
-
Regulating POLR3G by MicroRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivity.Noncoding RNA Res. 2023 Mar 9;8(3):273-281. doi: 10.1016/j.ncrna.2023.03.001. eCollection 2023 Sep. Noncoding RNA Res. 2023. PMID: 36949748 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
